Lung cancer is not the most common form of cancer, but it is by far among the deadliest. Despite treatments such as surgery, radiation therapy, and chemotherapy, only about a quarter of all people with the disease will live ...
Feb 23, 2024
0
15
Saint Louis University's Liz Chiarello, Ph.D., associate professor of sociology, recently published an article in the American Sociological Review. The article explores pharmacists' use of prescription drug monitoring programs ...
Feb 13, 2024
0
0
From invisible wafts of diesel exhaust to sun-choking plumes of orange smoke, air pollution is known to damage respiratory well-being. Now, research from Rutgers suggests another reason to hold our breath: Polluted air also ...
Nov 15, 2023
0
21
The HIV-1 virus can neutralize cellular defenses with its viral infectivity factor (Vif). OIST researchers Prof. Matthias Wolf and Dr. Takahide Kouno together with an international team of colleagues have now determined the ...
Jul 14, 2023
0
10
A new study by researchers at Children's Hospital of Philadelphia (CHOP) shows that linking a tumor-killing prodrug to a macromolecular carrier of the Poloxamer family improves retention of the drug in treatment-resistant ...
Mar 14, 2022
0
276
Following media reports of children with epilepsies reportedly deriving benefits from medical marijuana (or cannabis-based medicinal products) accessed abroad, the UK government allowed clinicians to prescribe these products. ...
Sep 9, 2021
0
16
Researchers at University of California San Diego School of Medicine and Rady Children's Institute for Genomic Medicine have produced a stem cell model that demonstrates a potential route of entry of SARS-CoV-2, the virus ...
Jul 16, 2021
2
252
A light-activated drug that can enter and kill cancer and bacterial cells without harming nearby healthy cells has been tested successfully in zebrafish and cells.
Jun 1, 2021
1
146
A new technology developed by UZH researchers enables the body to produce therapeutic agents on demand at the exact location where they are needed. The innovation could reduce the side effects of cancer therapy and may hold ...
May 17, 2021
1
934
Evidence suggesting an initial half dose of the vaccine being developed by drugs firm AstraZeneca and the University of Oxford is more effective than a full dose is counterintuitive, and even took the researchers by surprise.
Nov 23, 2020
0
9
